Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncology Institute, Inc. | Director | Common Stock | 676K | $310K | $0.46 | Jun 17, 2024 | Direct |
Oncology Institute, Inc. | Director | Non-Qualified Stock Option (right to buy) | 1.75M | Nov 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TOI | Oncology Institute, Inc. | Jun 17, 2024 | 1 | -$8.3K | 4 | Jun 20, 2024 | Director |
TOI | Oncology Institute, Inc. | May 22, 2024 | 1 | -$11.2K | 4 | May 23, 2024 | Director |
TOI | Oncology Institute, Inc. | Dec 26, 2023 | 1 | $0 | 4 | Dec 28, 2023 | Director |
TOI | Oncology Institute, Inc. | Nov 21, 2023 | 1 | -$56.7K | 4 | Nov 22, 2023 | Director |
TOI | Oncology Institute, Inc. | Nov 17, 2023 | 3 | -$34.8K | 4 | Nov 21, 2023 | Director |
TOI | Oncology Institute, Inc. | Nov 13, 2023 | 4 | -$143K | 4 | Nov 15, 2023 | Director |
TOI | Oncology Institute, Inc. | Mar 17, 2023 | 2 | $0 | 4 | Mar 21, 2023 | Chief Executive Officer, Director |
TOI | Oncology Institute, Inc. | Nov 17, 2022 | 2 | $0 | 4 | Nov 21, 2022 | Chief Executive Officer |
TOI | Oncology Institute, Inc. | Nov 15, 2022 | 1 | -$19.7K | 4/A | Nov 22, 2022 | Chief Executive Officer |
TOI | Oncology Institute, Inc. | Mar 21, 2022 | 1 | $0 | 4/A | Mar 29, 2022 | Chief Executive Officer, Director |
TOI | Oncology Institute, Inc. | Nov 12, 2021 | 2 | $0 | 4/A | Nov 18, 2021 | Chief Executive Officer, Director |
TOI | Oncology Institute, Inc. | Nov 12, 2021 | 0 | $0 | 3 | Nov 16, 2021 | Chief Executive Officer, Director |